To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
Vesalius Biocapital
A European life sciences venture capital investor
.
About us
News
Vesalius News
06/20/2025
Memo Therapeutics on WTC 2025
read more
06/11/2025
Memo Therapeutics: Study Transcytosis
read more
05/19/2025
Rejuvenate Biomed: First Patient
read more
.
xxnoxx_zaehler